Renal Cancer - Results from #6220

Sorafenib neoadjuvant therapy in the treatment of high risk renal cell carcinoma - Abstract May 20, 2015

Role of partial nephrectomy as cytoreduction in the management of metastatic renal cell carcinoma - Abstract May 20, 2015

Kidney cancer in Lebanon: A specific histological distribution? - Abstract May 20, 2015

Efficacy and toxicity of sunitinib for non clear cell renal cell carcinoma (RCC): A systematic review of the literature - Abstract May 20, 2015

Nephron-sparing surgery in renal cell carcinoma: Current perspectives on technical issues - Abstract May 20, 2015

Clinical outcomes related to the level of clamping in inferior vena cava surgery - Abstract May 18, 2015

Prognostic significance of visceral obesity in patients with advanced renal cell carcinoma undergoing nephrectomy - Abstract May 18, 2015

Bladder metastasis from renal cell carcinoma: Retrospective analysis of 65 reported cases - Abstract May 18, 2015

Alternate sunitinib schedules in patients with metastatic renal cell carcinoma - Abstract May 15, 2015

Recent aspects of sunitinib therapy in patients with metastatic clear-cell renal cell carcinoma: A systematic review of the literature - Abstract May 15, 2015

A rare cause of childhood renal cysts: Xp11.2 translocation renal cell carcinoma - Abstract May 15, 2015

A rare case of spontaneous necrosis of primary renal cell carcinoma - Abstract May 14, 2015

The impact of targeted therapy on management of metastatic renal cell carcinoma: Trends in systemic therapy and cytoreductive nephrectomy utilization - Abstract May 14, 2015

Five-year therapeutic experience of sorafenib for patients with advanced renal cell carcinoma - Abstract May 13, 2015

Which patients should we follow up beyond 5 years after definitive therapy for localized renal cell carcinoma? - Abstract May 13, 2015

Esophageal metastasis of renal cancer 10 years after nephrectomy - Abstract May 13, 2015

Phase II study of pazopanib as second-line treatment after sunitinib in patients with metastatic renal cell carcinoma: A Southern China Urology Cancer Consortium Trial - Abstract May 12, 2015

EAU Guidelines on renal cell carcinoma: 2014 Update - Abstract May 12, 2015

The European Medicines Agency approval of axitinib (Inlyta) for the treatment of advanced renal cell carcinoma after failure of prior treatment with sunitinib or a cytokine: - Abstract May 12, 2015

Radiation exposure from CT-guided ablation of renal masses: Effects on life expectancy - Abstract May 11, 2015

Page 312 of 456